Tag #Diabetes

Showing 73 to 84 of 123 results

elmundo.es

🌐 90% Global Worthiness

Feb 5, 07:10

Eleven Blockbuster Drugs to Transform Medicine by 2030

Clarivate's 2025 Drugs to Watch report identifies eleven innovative medicines projected to become blockbusters by 2030, significantly impacting various therapeutic areas, with diabetes/obesity and atopic dermatitis treatments anticipated to lead in revenue generation.

Eleven Blockbuster Drugs to Transform Medicine by 2030

Clarivate's 2025 Drugs to Watch report identifies eleven innovative medicines projected to become blockbusters by 2030, significantly impacting various therapeutic areas, with diabetes/obesity and atopic dermatitis treatments anticipated to lead in revenue generation.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the potential long-term implications of these new drugs on healthcare systems and patient access?

Future implications include potential shifts in treatment standards across multiple diseases. Cagrisema's success may reshape diabetes/obesity management, while Ebglyss and other new atopic dermatitis therapies could alter treatment strategies. In oncology, innovative mechanisms like PROTAC technology (vepdegestrant) could transform cancer treatment.

nbcnews.com

🌐 85% Global Worthiness

Feb 2, 13:06

Over-the-Counter Glucose Monitors: Benefits and Risks for Healthy Individuals

Continuous glucose monitors (CGMs), previously limited to diabetics, are now over-the-counter, enabling healthy individuals to track blood sugar in real time, potentially improving diet, sleep, and detecting early diabetes, despite limited research on long-term benefits for healthy people.

Over-the-Counter Glucose Monitors: Benefits and Risks for Healthy Individuals

Continuous glucose monitors (CGMs), previously limited to diabetics, are now over-the-counter, enabling healthy individuals to track blood sugar in real time, potentially improving diet, sleep, and detecting early diabetes, despite limited research on long-term benefits for healthy people.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate benefits and implications of readily available continuous glucose monitors for healthy individuals?

For healthy individuals, continuous glucose monitoring (CGM) offers insights into how lifestyle choices impact blood sugar, potentially aiding in early diabetes detection and healthier eating habits. Real-time data reveals the effects of food, stress, and sleep, empowering users to make informed decisions. This contrasts sharply with the limited, single-point-in-time data from traditional finger-prick methods.

dw.com

🌐 75% Global Worthiness

Jan 28, 22:12

GLP-1 RA Drugs Show Promise, but Limitations Remain

A study of 1.2 million medical records found that GLP-1 RA drugs, such as Ozempic and Wegovy, may reduce the risk of several health issues, including substance use disorders, psychiatric disorders, and dementia, by 8-18%, but also carry risks of nausea, vomiting, and pancreatic or kidney complicatio...

GLP-1 RA Drugs Show Promise, but Limitations Remain

A study of 1.2 million medical records found that GLP-1 RA drugs, such as Ozempic and Wegovy, may reduce the risk of several health issues, including substance use disorders, psychiatric disorders, and dementia, by 8-18%, but also carry risks of nausea, vomiting, and pancreatic or kidney complicatio...

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the broader systemic implications of this study's findings considering its limitations in sample representation and study design?

The study focused on GLP-1 receptor agonists (GLP-1 RAs), a class of drugs that includes Ozempic and Wegovy. These drugs affect brain receptors involved in impulse control, reward, and addiction, potentially explaining their impact on appetite and addiction disorders. The observed benefits were linked to the drugs' ability to reduce blood glucose levels and slow intestinal emptying.

dw.com

🌐 75% Global Worthiness

Jan 27, 13:09

Diabetes Drugs Linked to Reduced Risk of Mental Health Issues

A study of 1.2 million veterans' medical records found that the diabetes and weight-loss drugs Ozempic and Wegovy (GLP-1 receptor agonists) may be linked to a reduced risk of various mental health issues, including alcohol and substance use disorders, suicidal thoughts, schizophrenia, dementia, and ...

Diabetes Drugs Linked to Reduced Risk of Mental Health Issues

A study of 1.2 million veterans' medical records found that the diabetes and weight-loss drugs Ozempic and Wegovy (GLP-1 receptor agonists) may be linked to a reduced risk of various mental health issues, including alcohol and substance use disorders, suicidal thoughts, schizophrenia, dementia, and ...

Progress

24% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the long-term implications of this study, and what additional research is needed to explore potential therapeutic uses of GLP-1 RAs for mental health conditions?

Future research should focus on randomized controlled trials to confirm these findings and investigate the underlying mechanisms. The study's limitations, such as the predominantly white male veteran population, highlight the need for further investigation across diverse populations to determine the generalizability of these results. Understanding the precise impact of GLP-1 RAs on different neurological pathways will be crucial for potential therapeutic applications.

foxnews.com

🌐 85% Global Worthiness

Jan 23, 13:10

GLP-1 Drugs Show Significant Health Benefits and Risks in Large-Scale Study

A study of over two million veterans found that GLP-1 drugs, such as Ozempic, significantly reduce risks of neurocognitive disorders, addiction, and self-harm, but also increase the risk of pancreatic and kidney problems.

GLP-1 Drugs Show Significant Health Benefits and Risks in Large-Scale Study

A study of over two million veterans found that GLP-1 drugs, such as Ozempic, significantly reduce risks of neurocognitive disorders, addiction, and self-harm, but also increase the risk of pancreatic and kidney problems.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How do the mechanisms of action of GLP-1 drugs explain their observed effects on both cognitive function and addiction?

The study, published in Nature, establishes widespread associations between GLP-1 agonists and various health outcomes. These drugs impact brain receptors related to impulse control, reducing cravings. Weight loss and decreased brain inflammation are suggested as mechanisms for improved cognitive health.

dw.com

🌐 85% Global Worthiness

Jan 22, 19:09

Sugary Drinks Linked to Millions of Diabetes and Cardiovascular Disease Cases Globally

A study in Nature Medicine estimates that 2.2 million new type 2 diabetes cases and 1.2 million new cardiovascular disease cases worldwide in 2020 are potentially linked to sugary drinks, with sub-Saharan Africa, Latin America, and the Caribbean showing the highest proportions; researchers suggest i...

Sugary Drinks Linked to Millions of Diabetes and Cardiovascular Disease Cases Globally

A study in Nature Medicine estimates that 2.2 million new type 2 diabetes cases and 1.2 million new cardiovascular disease cases worldwide in 2020 are potentially linked to sugary drinks, with sub-Saharan Africa, Latin America, and the Caribbean showing the highest proportions; researchers suggest i...

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the estimated global impact of sugary drink consumption on type 2 diabetes and cardiovascular disease based on this study?

A study in Nature Medicine estimates that 2.2 million new type 2 diabetes cases and 1.2 million new cardiovascular disease cases globally in 2020 may be linked to sugary drinks. This represents about one in ten new type 2 diabetes cases and one in thirty new cardiovascular disease cases.

cnbc.com

🌐 75% Global Worthiness

Feb 4, 22:10

GLP-1 Drug Adherence: Cost, Side Effects, and Income Disparities

A JAMA Network Open study reveals that 65% of patients without diabetes stopped using GLP-1 weight loss drugs within a year, compared to 46% of those with Type 2 diabetes; side effects and cost were the main reasons, while higher income and weight loss correlated with continued use; Noom's layoffs e...

GLP-1 Drug Adherence: Cost, Side Effects, and Income Disparities

A JAMA Network Open study reveals that 65% of patients without diabetes stopped using GLP-1 weight loss drugs within a year, compared to 46% of those with Type 2 diabetes; side effects and cost were the main reasons, while higher income and weight loss correlated with continued use; Noom's layoffs e...

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does income influence GLP-1 medication adherence, and what are the broader implications for healthcare access and equity?

The study highlights the significant impact of cost and side effects on GLP-1 drug adherence. The findings suggest that factors beyond diabetes status, such as income and weight management, influence treatment persistence. This underscores the need for strategies addressing both patient access and long-term weight maintenance.

dw.com

🌐 75% Global Worthiness

Jan 31, 22:08

Ozempic and Wegovy May Reduce Risk of Multiple Diseases: Large-Scale Study

A study of 1.2 million veterans' health records suggests that Ozempic and Wegovy, GLP-1 receptor agonists, may reduce risks of schizophrenia, Alzheimer's, and substance abuse, although further research is needed due to the study's limitations.

Ozempic and Wegovy May Reduce Risk of Multiple Diseases: Large-Scale Study

A study of 1.2 million veterans' health records suggests that Ozempic and Wegovy, GLP-1 receptor agonists, may reduce risks of schizophrenia, Alzheimer's, and substance abuse, although further research is needed due to the study's limitations.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the key findings of this study regarding the impact of Ozempic and Wegovy on various health risks?

A large-scale study of 1.2 million medical records indicates that popular diabetes and weight-loss drugs, Ozempic and Wegovy, may reduce the risk of other diseases, including schizophrenia and Alzheimer's, by 18% and 12%, respectively. The study also showed a 10% reduction in suicidal thoughts or self-harm.

dw.com

🌐 75% Global Worthiness

Jan 27, 13:09

GLP-1RA Drugs Show Potential Link to Reduced Risk of Mental Health and Cognitive Conditions

A study of over 1.2 million veterans' medical records suggests a possible link between GLP-1 receptor agonist drugs, such as Ozempic and Wegovy, and a reduced risk of various mental health conditions, including suicidal thoughts, schizophrenia, dementia, and Alzheimer's disease, although further res...

GLP-1RA Drugs Show Potential Link to Reduced Risk of Mental Health and Cognitive Conditions

A study of over 1.2 million veterans' medical records suggests a possible link between GLP-1 receptor agonist drugs, such as Ozempic and Wegovy, and a reduced risk of various mental health conditions, including suicidal thoughts, schizophrenia, dementia, and Alzheimer's disease, although further res...

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How might the mechanisms of action of GLP-1RA drugs explain their potential impact on mental health and addiction?

The observed association between GLP-1RA use and reduced risk of mental health and cognitive decline issues may be linked to the drugs' impact on brain receptors involved in impulse control and reward. This is an observational study, however, so it doesn't establish causality, and further research is needed to confirm these findings and understand the underlying mechanisms.

forbes.com

🌐 85% Global Worthiness

Jan 26, 16:10

Samsung's Non-Invasive CGM: A Potential Game Changer

Samsung announced it is developing a non-invasive, optical continuous glucose monitor (CGM), a significant advancement in wearable health technology, potentially launching in a future Galaxy Watch or as a standalone device within the next year.

Samsung's Non-Invasive CGM: A Potential Game Changer

Samsung announced it is developing a non-invasive, optical continuous glucose monitor (CGM), a significant advancement in wearable health technology, potentially launching in a future Galaxy Watch or as a standalone device within the next year.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the significance of Samsung's development of a non-invasive continuous glucose monitor?

Samsung is developing a non-invasive continuous glucose monitor (CGM), a significant advancement in wearable health technology. This contrasts with current CGMs requiring skin penetration, potentially increasing accessibility and usage. Successful development could significantly impact diabetes management and broader health monitoring.

sueddeutsche.de

🌐 85% Global Worthiness

Jan 22, 04:11

Shift Work's Health Impacts: Risks, Adaptability, and Schedule Optimization

Shift work, especially night shifts, significantly impacts health, increasing risks of various diseases, including cancer, and disrupting sleep patterns. Adaptability varies with age and chronotype, with forward-rotating shifts and shorter workweeks recommended to minimize risks.

Shift Work's Health Impacts: Risks, Adaptability, and Schedule Optimization

Shift work, especially night shifts, significantly impacts health, increasing risks of various diseases, including cancer, and disrupting sleep patterns. Adaptability varies with age and chronotype, with forward-rotating shifts and shorter workweeks recommended to minimize risks.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does shift work affect sleep patterns and the prevalence of sleep disorders?

The impact of shift work extends beyond immediate health consequences. Studies show that while average sleep duration may not differ across shift types, sleep quality is significantly compromised after night shifts, often resulting in less than six hours of sleep. Furthermore, conditions like sleep apnea become more prevalent.

it.euronews.com

🌐 85% Global Worthiness

Jan 21, 01:09

Weight-Loss Drugs Show Reduced Alzheimer's Risk, But Increased Gastrointestinal Issues

A study of over two million US diabetic patients found that GLP-1 receptor agonist weight-loss drugs like Wegovy and Ozempic reduced the risk of Alzheimer's by 12%, drug/alcohol dependence, and some blood clotting issues, but increased risks of gastrointestinal problems, low blood pressure, and kidn...

Weight-Loss Drugs Show Reduced Alzheimer's Risk, But Increased Gastrointestinal Issues

A study of over two million US diabetic patients found that GLP-1 receptor agonist weight-loss drugs like Wegovy and Ozempic reduced the risk of Alzheimer's by 12%, drug/alcohol dependence, and some blood clotting issues, but increased risks of gastrointestinal problems, low blood pressure, and kidn...

Progress

32% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the significant health risks and benefits associated with GLP-1 receptor agonist weight-loss drugs based on the study of over two million patients?

A large-scale study of over two million US diabetic patients revealed that GLP-1 receptor agonist weight-loss drugs, like Wegovy and Ozempic, are associated with a reduced risk of various health issues, including Alzheimer's disease (12% reduction), drug/alcohol dependence, and certain blood clotting problems. However, these drugs also showed increased risks of gastrointestinal problems, low blood pressure, and kidney stones.

Showing 73 to 84 of 123 results